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ORIGINAL ARTICLE: INFERTILITYStudy Design, Size, Duration: A three-round Delphi survey (372 participants from 41 countries) and consensus development
workshop (30 participants from 27 countries).
Participants/Materials, Setting, Methods: Healthcare professionals, researchers, and people with fertility problems were brought
together in an open and transparent process using formal consensus science methods.
Main Results and the Role of Chance: The core outcome set consists of: viable intrauterine pregnancy confirmed by ultrasound (ac-
counting for singleton, twin, and higher multiple pregnancy); pregnancy loss (accounting for ectopic pregnancy, miscarriage, stillbirth,
and termination of pregnancy); live birth; gestational age at delivery; birthweight; neonatal mortality; and major congenital anomaly.
Time to pregnancy leading to live birth should be reported when applicable.
Limitations, Reasons for Caution: We used consensus development methods which have inherent limitations, including the represen-
tativeness of the participant sample, Delphi survey attrition, and an arbitrary consensus threshold.
Wider Implications of the Findings: Embedding the core outcome set within RCTs and systematic reviews should ensure the compre-
hensive selection, collection, and reporting of core outcomes. Research funding bodies, the Standard Protocol Items: Recommendations
for Interventional Trials (SPIRIT) statement, and over 80 specialty journals, including the Cochrane Gynaecology and Fertility Group,
Ferility and Sterility, and Human Reproduction, have committed to implementing this core outcome set.
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Randomized controlled trials (RCT) evaluating potential
fertility treatments should select, collect, and report outcomes
that are relevant to people with infertility and reflect the re-
alities of clinical practice (9). Unfortunately, many infertility
trials fall short of this requirement (37). Complex issues,
including a failure to take into account the perspectives of
people with infertility when designing RCT, variations in out-
comes, and selective reporting of outcomes, make research
evidence difficult to interpret, undermining the translation
of research into clinical practice (12).
Historically, there has been a limited emphasis upon the
engagement of people with fertility problems in the design of
research, which may have inadvertently led to the selection
of outcomes based upon the preferences of researchers. A sys-
tematic review has characterized outcome reporting across
infertility trials and demonstrates the wide variation in report-
ing, for example, the majority of infertility trials have not re-
ported live birth, major congenital anomalies, and adverse
events (5). Evenwhen relevant outcomes are reported, different
definitions can limit interpretation. For example, live birth has
been inconsistently defined, using different definitions,
including a viable fetus after 24 weeks of gestation, pregnancy
continuation beyond 28 weeks of gestation, and delivery of a
living baby (36). Such variation provides sufficient flexibility
for researchers to selectively report favorable results based
on statistical significance. Selective reporting of outcomes
basedon statistical significance, commonly referred to as result
cherry picking, is thought to be widespread across infertility192research and can result in the overestimation of treatment ef-
ficacy and underestimation of harm (12). Without consistent
outcome selection, collection, and reporting, evidence synthe-
sis can be challenging, and can make comparisons and
combining these data within a meta-analysis impossible (2).
These problems can be addressed by the development of a
core outcome set for RCT and systematic reviews evaluating
potential treatments for infertility. A core outcome set repre-
sents a minimum collection of particularly important out-
comes and outcome measures which have been developed
using formal consensus methods engaging health care profes-
sionals, researchers, and people with fertility problems (9).
Core outcomes should be routinely utilized by researchers,
collected in a standardized manner, and reported consistently
in the final publication (4).
Motivated by the desire to increase the utility of future
infertility research, an international collaboration embedded
within the Cochrane Gynaecology and Fertility Group, has
brought health care professionals, researchers, and people
with fertility problems together to develop a core outcome
set for future infertility research.
MATERIALS AND METHODS
The study was prospectively registered with the Core Outcome
Measures in Effectiveness Trials (COMET) initiative, registra-
tion number 1023. An international steering group, including
health care professionals, researchers, and people with
fertility problems, was established. The steering group was
convened during the development of the study protocol,VOL. 115 NO. 1 / JANUARY 2021
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consensus development meeting, to obtain advice regarding
the participant sample, data collection, and data analysis.
The core outcome set was developed in a three-stage pro-
cess using consensus science methods advocated by the
COMET initiative (39). A protocol describing the methods
has previously been published (11). The protocol was
informed by a systematic review of registered, progressing,
and completed core outcome sets relevant to women’s and
newborn health (10) and the experiences of steering group
members involved in other core outcome set development
studies (7, 20, 21, 23, 24, 32, 35).
The important work of the Harbin Consensus Working
Group (18) and International Committee for Monitoring As-
sisted Reproductive Technologies (40) is complementary to
this study.
A comprehensive inventory of outcomes was developed
by extracting outcomes from systematic reviews that had
already quantified outcome reporting across infertility trials
(2, 5, 36). Lay definitions were developed for individual out-
comes. The outcome inventory and lay definitions were
entered into a modified Delphi method (26).
The study aimed to recruit key stakeholders including
health care professionals, researchers, and people with
fertility problems. Healthcare professionals and researchers
were recruited through the British Fertility Society, Core Out-
comes in Women’s and Newborn Health initiative, Cochrane
Gynaecology and Fertility Group, International Federation
of Fertility Societies, the International Federation of Gynecol-
ogy and Obstetrics Committee for Reproductive Medicine,
Endocrinology, and Infertility, Reproductive Medicine Clin-
ical Study Group, and Royal College of Obstetricians and Gy-
naecologists. People with fertility problems were recruited
through Fertility Europe, Fertility Network UK, Fertility New
Zealand, and RESOLVE: The National Infertility Association.
Recruitment was supported by an active social media
campaign. The Delphi method does not depend on statistical
power. Working from its underlying principles, group error
should decrease and the decision quality increase as the num-
ber of participants increases. Between 10 and 15 participants
have been demonstrated to yield sufficient results and assure
validity (26). Anticipating a 20% attrition rate, we aimed to
recruit 18 participants for each stakeholder group.
The modified Delphi method was delivered through
sequential online surveys using Delphi survey software (Del-
phi Manager, University of Liverpool, Liverpool, UK). Poten-
tial participants received an explanatory video abstract, a
plain language summary, and Delphi survey instructions. In
round one, participants scored individual outcomes on a
nine-point Likert scale. Participants were able to select an
‘unable to score’ category if they considered themselves not
to have sufficient expertise or experience to score an individ-
ual outcome. Before completing the survey, participants were
able to suggest additional outcomes. After the round one sur-
vey had closed, the scores for each outcome were aggregated
across individual stakeholder groups. The percentage of par-
ticipants scoring each outcome at every possible response
from one to nine was calculated and tabulated for individual
stakeholder groups: healthcare professionals, researchers, andVOL. 115 NO. 1 / JANUARY 2021people with fertility problems. Additional outcomes were
considered by the steering group and novel outcomes were
entered into the round two survey.
In round two, participants were asked to reflect on their
own scores and on the scores of other participants, before re-
scoring each outcome. Before completing the survey, partici-
pants were able to score additional outcomes suggested by
participants in the round one survey. After the round two sur-
veys had closed, the percentage of participants scoring each
outcome at every possible response from one to ninewas calcu-
lated and tabulated for individual stakeholder groups. An a pri-
ori consensus definition, a median score of eight in each
stakeholder group, was applied to identify consensus outcomes.
The round two Delphi survey results were reviewed by the
steering group to consider whether a further Delphi survey
round was required. The steering group members concluded
it was unlikely a further Delphi survey round would identify
additional consensus outcomes. However, as there is uncer-
tainty regarding the use of the modified Delphi method in
core outcome set development, the steering group recommen-
ded proceeding with a third Delphi survey round, to ensure
that no further consensus outcomes would have been identi-
fied (39).
Following the round two survey, a face-to-face
consensus development meeting was arranged. A modified
Nominal Group Technique was used to further prioritize
consensus outcomes. Healthcare professionals, researchers,
and people with fertility problems who had completed all
three rounds of the Delphi survey were invited to participate.
The modified Nominal Group Technique does not depend on
statistical power. In consultation with the steering group,
we aimed to recruit between 10 and 15 participants, as this
number has yielded sufficient results and assured validity in
other settings (26).
The modified Nominal Group Technique provides an op-
portunity to generate ideas, which are discussed, and ranked
by a group of experts (26). At the start of the meeting, the re-
sults of the Delphi survey were reviewed. All potential core
outcomes reaching the standardized consensus definition
were entered into the process. Participants were able to enter
other potential core outcomes which had not reached the
standardized consensus definition, upon request. Each partic-
ipant was asked to contribute their opinions. Following the
initial discussion, outcomes were divided into three initial
categories: outcomes to be considered for inclusion in the
final core outcome set; outcomes where no consensus existed;
and outcomes which should not be considered for inclusion in
the final core outcome set. Participants were invited to discuss
the ordering of the outcomes within each category. The dis-
cussion focused upon ranking the outcomes being considered
for inclusion in the final core outcome set and the outcomes
where no consensus existed. During the discussion, the out-
comes could be moved between the categories. Finally, the
core outcome set was agreed.RESULTS
An outcome inventory, which included 101 outcomes, was
developed (Supplementary Table S1). These outcomes were193
ORIGINAL ARTICLE: INFERTILITYthematically ordered into 23 thematic domains, including
early pregnancy outcomes, patient reported outcomes, and
adverse events immediately following treatment. Outcome
domains, outcomes, and lay definitions were entered into
the modified Delphi method.
When considering the Delphi survey, round one was
completed by 261 healthcare professionals, 57 researchers,
and 54 people with fertility problems, from 41 countries
(Table 1). Round two was completed by 275 participants
and round three was completed by 227 participants. One hun-
dred and one outcomes were entered into the Delphi survey
(Fig. 1). In response to the outcomes suggested by partici-
pants, the steering group added 32 additional outcomes to
round two, including cumulative live birth, experimental
intervention feasibility, and cost effectiveness. Therefore,
133 outcomes were scored during round two. Following
round two, 28 outcomes reached the consensus threshold.
No additional consensus outcomes were identified following
the completion of the round three survey.
Fifteen healthcare professionals, six researchers, and nine
people with fertility problems, including four men with
fertility problems, from 27 countries, participated in the
consensus development meeting. Twenty-eight consensus
outcomes were entered into the modified Nominal Group
Technique. Participants entered an additional eight no
consensus outcomes into the process. These outcomes had
been highly scored by people with infertility (median score
nine), however, had not met the consensus threshold because
of lower scores in other stakeholder groups. Participants
prioritized outcomes for inclusion in the core outcome set
for infertility (Fig. 2).TABLE 1
Participant characteristics.
Modified Delphi m
Round 1 n[372 Round 2 n[275 Round
Stakeholder group, n
Health professionals 261 203 1
Researchers 57 44
People with infertility 54 28
Gender, n
Male 124 94
Female 244 178 1
Not stated 4 3
Age (years), n
Under 29 75 64
30 to 39 116 81
40 to 49 76 54
50 to 59 7 54
Over 60 22 18




Australia and New Zealand 42 34
Europe 134 92
North America 37 26
South America 15 9
Prefer not to say 13 10
Duffy. Core outcomes for infertility research. Fertil Steril 2020.
194DISCUSSION
Using formal consensus science methods, health care profes-
sionals, researchers, and people with fertility problems have
developed a core outcome set which should be used to stan-
dardize outcome selection, collection, and reporting across
RCT and systematic reviews evaluating potential treatments
for infertility.
The COMET initiative has recently published methodolog-
ical standards for core outcome set development (25). This study
has met these standards. With 372 participants, from 41 coun-
tries, participating in the Delphi survey and 30 participants,
from 27 countries, participating in the consensus development
meeting, the global participation achieved in this study should
secure the generalizability of the results across diverse research
settings. The study included people with fertility problems as
steering group members and participants. As participants,
they shared their views regarding the importance of potential
core outcomes during the Delphi survey and participated fully
in the consensus development meeting, which prioritized the
final core outcome set. This contribution should ensure thefinal
core outcome set holds the necessary reach and relevance to
people with fertility problems.
This consensus study is not without limitations. Consider-
ation should be given to the representativeness of the study’s
participants. When considering the Delphi survey, there was a
higher response from participants who lived in Europe (134
participants; 36%). To participate in the Delphi survey, En-
glish proficiency, a computer, and internet access were
required. We appreciate limitations in the representativeness
of the sample could have impacted upon the outcomes
prioritized.ethod Modified nominal group technique
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FIGURE 1
101 potential core outcomes















Core outcome set for future infertility research
28 consensus outcomes entered
Final consensus
8 outcomes entered by participants
Systematic review
133 potential core outcomes scored
Flow of participants and outcomes.
Duffy. Core outcomes for infertility research. Fertil Steril 2020.
Fertility and Sterility®There is considerable uncertainty regarding core outcome
set development methods (8, 13, 39). The optimal approaches
to selecting participants, structuring interactions, and
methods of synthesizing individual judgements are unclear
(26). Further methodological research is required to inform
future core outcome set development (39).
The Delphi survey’s overall attrition rate was 38%, which
is comparable to other core outcome development studies
(10). Participants who identified as people with fertility prob-
lems were more likely to withdraw. It may have been possible
to reduce attrition by reducing the length of the survey; for
example, limiting the outcomes entered into the Delphi sur-
vey, removing outcomes which reached consensus in subse-
quent survey rounds, or reducing the number of survey
rounds. However, attrition needed to be balanced with the
requirement to enter a comprehensive long list of potential
core outcomes into the Delphi survey and for participants to
be able to reflect on and rescore individual outcomes in rela-
tion to each other. Further methodological research is
required to understand the impact of attrition on the develop-
ment of consensus within core outcome set development
studies.VOL. 115 NO. 1 / JANUARY 2021Many international initiatives, professional societies, and
colleagues have strongly advocated for the collection and re-
porting of many of the core outcomes, including live birth,
pregnancy loss, and adverse events (1, 18). Despite the clear
articulation of the importance of these outcomes, poor report-
ing persists with only one-third of infertility trials reporting
live birth (36). Why will this time be different? The Core
Outcome Measure for Infertility Trials (COMMIT) initiative
has developed a strategic plan in consultation with a broad
range of stakeholders across the research pipeline to utilize
available enablers to secure the routine selection, collection,
and reporting of core outcomes across future fertitly research
(6).
Research funding bodies are increasingly advocating for
the use of core outcome sets within the research they fund.
It is considered good practice for researchers planning RCT
to follow the SPIRIT statement, which outlines the scientific,
ethical, and administrative elements that should be incorpo-
rated in a clinical trial protocol (3). This statement specifically
recommends the collection of core outcomes.
This study has established a core outcome set for infer-
tility, however different definitions exist for individual core195
FIGURE 2
 Viable intrauterine pregnancy confirmed by ultrasound. Accounting for singleton
pregnancy, twin pregnancy, and higher multiple pregnancy.
 Pregnancy loss. Accounting for ectopic pregnancy, miscarriage, stillbirth, and termination
of pregnancy. 
 Live birth.
 Gestational age at delivery.
 Birth weight.
 Neonatal mortality.
 Major congenital anomaly.
*When applicable → time to pregnancy leading to live birth.
A core outcome set for future infertility research.
Duffy. Core outcomes for infertility research. Fertil Steril 2020.
ORIGINAL ARTICLE: INFERTILITYoutcomes. The study has recently developed standardized def-
initions, using formal consensus development methods, for
individual core outcomes. This additional harmony across
future infertility trials should ensure secondary research can
be undertaken prospectively, efficiently, and harmoniously
(15). This standardization will be supported by the develop-
ment of a freely available electronic case report form and
data repository, which future researchers will be encouraged
to use for data collection (COMMIT-Collection). Several core
outcomes, including live birth, birthweight, and neonatal
mortality, are common to other core outcome sets developed
for hyperemesis gravidarum, multiple pregnancy research
and neonatal care (22, 28, 29, 34). Additional consistency
could be achieved across our specialty if the consensus defi-
nitions developed within this initiative were embedded within
these core outcome sets.
The CROWN initiative, supported by over 80 specialty
journals, including the Cochrane Gynaecology and Fertility
Group, Ferility and Sterility, and Human Reproduction, has
resolved to implement this core outcome set (4). CROWN
initiative journals will advise researchers to report the core
outcome set for infertility within trial reports and offer con-
clusions based on these outcomes. Where core outcome sets
have not been collected, the researchers will be asked to report
this deficiency and its implications for their findings. The
COMMIT initiative is currently developing reporting tools
and templates to assist researchers to clearly report core out-
comes within their manuscripts (COMMIT-Reporting).
Analyses of data arising from infertility trials, particu-
larly for studies related to ART, are frequently undermined
by the use of an inappropriate denominator (36). Twomain is-
sues exist. The first is the use of a post-randomization denom-
inator, for example, when live birth rates are calculated per
embryo transferred, rather than per woman randomized. An-
alyses conducted on this basis do not reflect the randomized
comparisons as the groups being compared may differ with
respect to their characteristics, and therefore, also with respect196to their outcomes (19). The second issue relates to analyses
which commit a unit of analysis error (31). This error occurs
when proportions are calculated using an inappropriate de-
nominator, for example, the number of oocytes or number
of embryos. Unit of analysis errors commonly occur when re-
searchers calculate the pregnancy rate by dividing the number
of gestational sacs on ultrasound by the number of embryos
transferred. As the outcomes of a couple’s embryos are corre-
lated, this approach is incorrect as standard statistical tests as-
sume that the tested observations are independent. To address
these important issues the COMMIT initiative has resolved to
reach clear recommendations regarding the selection of the
most appropriate denominator (15).
The Cochrane Gynaecology and Fertility Group have pub-
lished over 100 systematic reviews evaluating potential treat-
ments for infertility and has committed to implementing the
core outcome set for infertility when new and updated re-
views are being prepared. Secondary research, including pair-
wise meta-analyses, individual participant data meta-
analyses, and networkmeta-analyses, will be more influential
when infertility trials routinely collect and report core
outcomes.
The COMMIT initiative has committed to undertaking
further research to assess the uptake and implementation of
the core outcome set for infertility (COMMIT-Implementa-
tion). Objectively demonstrating the uptake of the core
outcome set for infertility is important to quantify its contri-
bution to improve the value of future research. Assessing the
uptake of the core outcome set will be undertaken by exam-
ining registry records, published protocols, RCT, and system-
atic reviews, and undertaking a citation analysis. Further
research is planned to examine and understand the reasons
why researchers do, and do not, implement the core outcome
set for infertility. By identifying perceived barriers to imple-
mentation, strategies informed by implementation science
will be developed to limit, and hopefully overcome, any
perceived barriers.VOL. 115 NO. 1 / JANUARY 2021
Fertility and Sterility®The core outcome set reported in this study is intended to
be used across trials evaluating a broad range of potential
fertility treatments, for example, male endocrine stimulation
protocols, lifestyle interventions for people with fertility
problems, and methods for embryo selection during IVF cy-
cles. Extensions to the current core outcome set are planned
or currently in development for different patient populations,
including men with fertility problems (COMMIT-Male Infer-
tility), women with endometriosis (16), and interventions
including IVF (COMMIT-IVF). Other extensions are planned
to ensure future infertility trials and systematic reviews
routinely collect and report harms (COMMIT-Harms).
Although quality of life was not selected as a core outcome,
the COMMIT initiative has committed to undertaking a sys-
tematic review and methodological assessment of measure-
ment instruments capable of measuring quality of life, and
will make recommendations to inform the design of future
infertility trials (COMMIT-QoL).
This comprehensive strategy could make a significant
contribution in reducing research waste across future fertility
research. This approach has acted as a template for other areas
of women’s health seeking to tackle research waste, including
twin and multiple pregnancy research (30). The variation in
outcome reporting and suspected outcome reporting bias
has been characterized across women’s and newborn health,
including endometriosis, twin-twin transfusion syndrome,
and neonatal care. This study should inform the development
of other core outcome sets seeking to tackle poorly selected,
collected, and reported outcomes (21, 27, 33).
Research priority setting presents an opportunity to
develop a prioritized research agenda (17). A research priority
setting study has recently been completed for infertility and
identified research priorities related to the prevention, diag-
nosis, and treatment of male, female, and unexplained infer-
tility (14). Undertaking a RCT is the only appropriate method
to answer many of these research priorities (38). Therefore, it
is important for our specialty to work together to improve the
design, delivery, and reporting of future trials.
In summary, this study used formal consensus methods to
develop a core outcome set for future RCT and systematic re-
views evaluating potential treatments for infertility. Embed-
ding the core outcome set within future infertility research
could make a profound contribution to advancing the useful-
ness of research to inform clinical practice and enhance the
care people with infertility problems receive.APPENDIX. CORE OUTCOME MEASURE FOR
INFERTILITY TRIALS (COMMIT) INITIATIVE
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ductiva, Argentina; Dr Ingrid Granne, University of Oxford,
UK; Professor Georg Griesinger, University Hospital of
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